Literature DB >> 12635814

Cytokine regulation of P-glycoprotein.

Mary Peace McRae1, Kim L R Brouwer, Angela D M Kashuba.   

Abstract

P-glycoprotein (Pgp) is a membrane bound transporter involved in the disposition of many endogenous compounds and xenobiotics. Alterations in Pgp expression and activity can significantly affect the disposition of Pgp substrates. Infection and inflammatory stimuli have also been shown to alter drug disposition. However, the specific effects of inflammation on Pgp expression and activity are not well understood. This paper evaluates and summarizes the current literature on the effects of cytokines and inflammation on mRNA and protein expression as well as functional activity of Pgp in whole animal models, primary rodent hepatocytes and human carcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635814     DOI: 10.1081/dmr-120018247

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  13 in total

Review 1.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

Review 2.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

Review 3.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Systems Biology Approaches to Enzyme Kinetics.

Authors:  Nnenna A Finn; Andrew D Raddatz; Melissa L Kemp
Journal:  Methods Mol Biol       Date:  2021

5.  Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.

Authors:  Fatemeh Mosaffa; Fatemeh Kalalinia; Herman Lage; Jalil Tavakol Afshari; Javad Behravan
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

6.  The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model.

Authors:  Kelstan Ellis; Jerry W Marlin; Tracey A H Taylor; Sylvia Fitting; Kurt F Hauser; Greg Rice; MaryPeace McRae
Journal:  J Pharm Pharmacol       Date:  2014-12-31       Impact factor: 3.765

7.  Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells.

Authors:  Mohammad M Al-Bataineh; Deon van der Merwe; Bruce D Schultz; Ronette Gehring
Journal:  Biopharm Drug Dispos       Date:  2010-10-22       Impact factor: 1.627

8.  Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX.

Authors:  Fatemeh Mosaffa; Hermann Lage; Jalil Tavakol Afshari; Javad Behravan
Journal:  Inflamm Res       Date:  2009-03-31       Impact factor: 4.575

9.  Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier.

Authors:  Majid Iqbal; Hay Lam Ho; Sophie Petropoulos; Vasilis G Moisiadis; William Gibb; Stephen G Matthews
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

Review 10.  The complexities of hepatic drug transport: current knowledge and emerging concepts.

Authors:  Priyamvada Chandra; Kim L R Brouwer
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.